Organization
Brazilian Gynecologic Oncology Group (EVA)
1 abstract
Abstract
A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.Org: Hospital São Lucas da PUCRS, Hospital Fêmina - Grupo Hospitalar Conceição, Brazilian Gynecologic Oncology Group (EVA), Latin American Cooperative Oncology Group (LACOG), Division of Clinical Research and Technological Development - Brazilian National Cancer Institute (INCA),